Presentations in this session:

10:20 TuOa0101    Abstract Control of viremia after antiretroviral treatment and therapeutic vaccination with novel forms of DNA vaccines in chronically SIVMAC251-infected macaques Felber B.1, von Gegerfelt A.1, Rosati M.1, Alicea C.1, Roth P.1, Bear J.1, Valentin A.1, Boyer J.2, Weiner D.3, Bischofberger N.4, Markham P.5, Albert P.6, Franchini G.6, Pavlakis G.1 1NCI, Frederick, United States of America, 2U. of Pennsylvania, Pensylvania, United States of America, 3U. of Pennsylvania, Philadelphia, United States of America, 4Gilead, Foster City, United States of America, 5ABL, Inc., Kensington, United States of America, 6NCI, Bethesda, United States of America

10:35 TuOa0102    Abstract Immune modulation in HAART-naïve, asymptomatic HIV-infected individuals undergoing therapeutic vaccination with HIV-1 whole killed vaccine Gori A.1, Trabattoni D.2, Rizzardini G.3, Maserati R.4, Schenal M.2, Fasano F.2, Mazzotta F.5, Theofan G.6, Bray D.H.7, Clerici M.2 1Institute of Infectious Diseases and Tropical Medicine, “L. Sacco” Hospital, Milano, Italy, 2Chair of Immunology, University of Milano, Milano, Italy, 3H. di Circolo, Busto Arsizio (VA), Italy, 4H S Matteo IRCCS, Pavia, Italy, 5H. SS Annunziata, Firenze, Italy, 6The Immune Response Corporation, Carlsbad, CA 92008, United States of America, 7Medical Research Council Clinical Trials Unit, London, United Kingdom

10:50 TuOa0103    Abstract Cross clade CD8+ T cell responses in primary HIV-1 clade B infection Malhotra U.1, Nolin J.1, Maenza J.1, McElrath M.J.1 1Fred Hutchinson Cancer Research Center, Seattle, United States of America

11:05 TuOa0104    Abstract Host genetics, viral sequence diversity and antiviral cellular and humoral immunity in HIV-1 clade B infected individuals in Peru Zuniga R.1, Lucchetti A.1, Galvan P.1, Sanchez S.1, Peinado J.1, Frahm N.2, Linde C.2, Hewitt H.2, Hildebrand W.H.3, Montefiori D.4, Allen T.2, Altfeld M.2, Walker B.D.2, Sanchez J.1, Brander C.2 1Asociación Civil IMPACTA Salud y Educación, Lima, Peru, 2Partners AIDS Research Center, Boston, MA, United States of America, 3University of Oklahoma, Oklahoma City, OK, United States of America, 4Laboratory for AIDS Vaccine Research & Development, Duke University Medical, Durham, NC, United States of America

11:20 TuOa0105    Abstract Powerpoint An extremely common major histocompatibility complex class I allele in Mauritian cynomolgus macaques Krebs K.1, Rudersdorf R.1, Jin Z.1, OConnor D.1 1University of Wisconsin at Madison, Madison, United States of America

11:35 TuOa0107    Abstract Powerpoint Assessing potential candidates for HIV prevention trials in a very poor area of Rio de Janeiro State, Brazil Velasco de Castro C.1, Grinsztejn B.2, Veloso V.G.2, Bastos F.I.3, Pilotto J.H.4, Paiva M.2, Friedman R.2, Moreira R.I.2, Morgado M.G.5 1IPEC/IOC/IFF - Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, 2IPEC- Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, 3CICT - Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, 4Hospital Geral de Nova Iguacu/ I